Patricia A. Oelrich, Ph.D., CPA, CISA, has served as an Independent Director since 2014. In 2019, she was reelected for a five-year term ending in 2024. Ms. Oelrich was a member of the Board of Directors of USA Technologies, Inc. from April 2019 to June 2020 and was a member of the Board of Directors of Pepco Holdings, Inc. from May 2010 until April 2016 when it was sold to Exelon Corporation. She is also on the Board of the Association of Audit Committee Members, Inc. From 1995 to 2009, she was with GlaxoSmithKline Pharmaceuticals as Vice President, Internal Audit and then as Vice President, IT Risk Management. Prior to joining GlaxoSmithKline, Ms. Oelrich was an Audit Partner with Ernst & Young, serving the audit assurance practice from 1975-1995. She spent two years in Ernst & Young's National Office Audit Assurance Group developing audit guidance and providing financial accounting interpretations to offices throughout the U.S. In 1988, she became a Partner and headed the Information Technology Audit and Security Practice in Chicago from 1988 to 1995. In addition to heading the Information Technology Audit and Security Practice, Ms. Oelrich was also lead Partner on various audit engagements. Ms. Oelrich is Co-Chair of the Advisory Board for the Raj and Kamla Gupta Governance Institute, member of the NACD, Chair of the board for the NACD New Jersey Chapter, and member of the Women Corporate Directors Philadelphia. She was recognized as NACD Directorship Certified under the NACD's certification program in 2021 and obtained a CERT Certificate in Cybersecurity Oversight from the CERT Division of the Software Engineering Institute at Carnegie Mellon University in 2023. Ms. Oelrich has also served as principal of Oelrich & Associates, LLC since April 2011, where she counsels clients regarding matters of corporate governance. Ms. Oelrich received a Ph.D. and an M.A. in Human Organizational Systems from Fielding Graduate University and a B.B. in Accounting and Information Systems from Western Illinois University.

Board of Directors Page